Cerity Partners’s LivaNova LIVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Sell
26,834
-811
-3% -$57.4K ﹤0.01% 1539
2026
Q1
$1.76M Buy
27,645
+4,817
+21% +$311K ﹤0.01% 1559
2025
Q4
$1.4M Buy
22,828
+2,959
+15% +$169K ﹤0.01% 1535
2025
Q3
$1.04M Buy
19,869
+266
+1% +$13.4K ﹤0.01% 1586
2025
Q2
$883K Buy
+19,603
New +$809K ﹤0.01% 1578
2025
Q1
– Sell
-11,043
Closed -$514K – 2553
2024
Q4
$514K Buy
11,043
+136
+1% +$6.97K ﹤0.01% 1744
2024
Q3
$573K Buy
+10,907
New +$541K ﹤0.01% 1701

Other funds holding LIVN

Cerity Partners's LIVN Position: Q2 2026 in Review

Cerity Partners reduced its LivaNova (LIVN) stake by 2.9% in Q2 2026, selling an estimated $57.4K and leaving 26,834 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1539.

Cerity Partners first reported a position in LIVN in Q3 2024 and has held it in 7 quarters since. 303 funds tracked by Wall St. Rank hold LIVN as of Q2 2026.

  • Cerity Partners held 26,834 shares of LivaNova worth $2.21M as of Q2 2026.
  • Cerity Partners sold 811 LivaNova shares in Q2 2026, an estimated $57.4K.
  • LivaNova made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1539 holding.
  • Cerity Partners first reported a position in LivaNova in Q3 2024 and has held it in 7 quarters since.
  • 303 funds tracked by Wall St. Rank held LivaNova as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.